November 18th, 2026Executive Conversations: Where Traditional Channel Models Break DownIn Episode 2, Part 2, Cheryl Allen, Nick Calla and Rena Goins discuss where traditional channel models break down as therapies grow more complex.Read more
November 18th, 2026UPS to Acquire Smartways Logistics, Expanding APAC Health Care ReachUPS' deal for Smartways Logistics adds a dedicated health care courier network in Australia and New Zealand to its Asia Pacific buildout.Read more
November 18th, 2026Trump Pulls Overton's FDA Nomination Ahead of Senate HELP VoteThe White House pulled Heidi Overton's FDA nomination a day before a Senate HELP vote, leaving acting Commissioner Kyle Diamantas in charge.Read more
November 17th, 2026Executive Conversations: Why Channel Design Should Start With the PatientIn Episode 2, Part 1, Cheryl Allen, Nick Calla and Rena Goins discuss whether today's channel models are ready for an increasingly complex pipeline.Read more
November 17th, 2026How Retrofitting Idle US Plants Could Speed Drug ReshoringAPIIC's Brian Doty on how repurposing shuttered U.S. plants with advanced manufacturing could make domestic generic drug production viable.Read more
November 16th, 2026Executive Conversations: What Sets Strategic Trade Teams Apart?In Episode 1, Part 4, Jon Hamrick, Rena Goins and Bob Cochran explain what separates trade teams seen as strategic partners from those that aren't.Read more
November 16th, 2026Commercial Pharma Has a Data Debt Problem. Why Minimum Payments Won't Fix It.Fragmented data is eroding trust in pharma insights, and AI raises the stakes. A four-step approach can help organizations pay down their “data debt.”Read more
November 13th, 2026Why the Next Wave of Drug Launches Will Be Won on Market AccessThani Jambulingam, Ph.D., says MFN pricing, Section 232 tariffs and PBM reform will converge to shape how pharma launches and commercializes new drugs.Read more